Latest news
Corbus Pharmaceuticals (NASDAQ:CRBP) Cut to "Strong Sell" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTCorbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatchMarketWatch · Fri, 07 Aug 2026 21:19:00 GMTCRBP (NASDAQ: CRBP) insider plans 12,000-share sale via Stifel - Stock TitanStock Titan · Fri, 07 Aug 2026 20:24:21 GMTCRBP (CRBP) holder files to sell 17,000 Nasdaq-traded shares - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:13 GMTCRBP Maintained by Oppenheimer -- Price Target Lowered to $48.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 16:47:43 GMTCRBP Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocusGuruFocus · Fri, 07 Aug 2026 15:33:45 GMTOppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:44:11 GMTHC Wainwright Has Lowered Expectations for Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:21:54 GMT